Ligand · KJV
KJV · 4-(dimethylamino)-N-[3-(4-{[(1S)-2-hydroxy-1-phenylethyl]amino}-6-phenylfuro[2,3-d]pyrimidin-5-yl)phenyl]butanamide
KJV, 4-(dimethylamino)-N-[3-(4-{[(1S)-2-hydroxy-1-phenylethyl]amino}-6-phenylfuro[2,3-d]pyrimidin-5-yl)phenyl]butanamide (C32 H33 N5 O3, 535.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding…
- Component
- KJV
- Formula
- C32 H33 N5 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
KJV in 2 structures; the first of them:
- 4JRV · Crystal structure of EGFR kinase domain in complex with compound 4c · KJV A1001 · binds LEU694, GLY695, PHE699, VAL702, ALA719, LYS721, GLU738, MET742 and 13 more
- 4JRV · Crystal structure of EGFR kinase domain in complex with compound 4C · KJV A1001 · binds LEU694, GLY695, PHE699, VAL702, ALA719, LYS721, GLU738, MET742 and 13 more
Residues it binds most
LEU 2, ASP 2, GLY 2, MET 2, THR 2, ALA 2, ARG 2, ASN 2, GLN 2, GLU 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.